Low-dose vasopressin for kidney protection after liver transplant
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests whether giving a low dose of a hormone called vasopressin after a liver transplant can help prevent kidney injury. It's for adults scheduled for a planned liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled to receive a liver transplant
- You are not having an emergency transplant or sudden liver failure
- You do not have severe kidney disease (dialysis or very low kidney function)
- You do not have epilepsy or an allergy to the study drug (vasopressin)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This trial tests if a drug called vasopressin can help prevent acute kidney injury in patients at high risk. It's for adults in the ICU who have a predicted risk score of 5 or higher based on their lab and health data.
This study tests whether giving amino acids (the building blocks of protein) before and after surgery can help protect the kidneys of people receiving a liver transplant. It may reduce the risk of kidney injury during recovery.
This trial tests whether giving L-arginine (a natural amino acid) soon after heart surgery can help protect your kidneys. It is for adults who had heart surgery with a heart-lung machine and did not have kidney problems before surgery.
This trial tests if giving amino acids through a vein during surgery can help prevent kidney damage after a living-donor liver transplant. If you are an adult having this type of transplant, this treatment might protect your kidneys.
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
Hear when a new Acute Kidney Injury Post Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.